S66 0.00% 13.5¢ star combo pharma limited

Ann: Termination of the Bio-E Share Sale Agreement, page-10

  1. 880 Posts.
    lightbulb Created with Sketch. 156
    S66 is a good business, strong cash flows, the right distribution channels and decent growth to date.

    Surprised by the lack of trading on this stock.

    I'm expecting another acquisition announcement before the end of calendar year, especially after the failed Bio-E deal. They should leverage up the company and use debt to expand.
 
watchlist Created with Sketch. Add S66 (ASX) to my watchlist
(20min delay)
Last
13.5¢
Change
0.000(0.00%)
Mkt cap ! $18.23M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 10000 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 18242 2
View Market Depth
Last trade - 16.12pm 09/07/2024 (20 minute delay) ?
S66 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.